Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

647
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
647
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

501
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
501
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.2K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.2K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

584
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
584

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning With Optical Coherence Tomography for Glaucoma Diagnosis.

Journal of glaucoma·2026
Same author

Association Between 24-Hour Blood Pressure and Rates of Retinal Nerve Fiber Layer Progression in Glaucoma: The Vascular Imaging in Glaucoma Study.

American journal of ophthalmology·2026
Same author

Detecting glaucoma progression through optic nerve head hemoglobin concentration using automated colorimetric analysis.

European journal of ophthalmology·2026
Same author

Editorial: Imaging in glaucoma.

Frontiers in medicine·2026
Same author

Performance of a Small Language Model Versus a Large Language Model in Answering Glaucoma Frequently Asked Patient Questions: Development and Usability Study.

JMIR AI·2026
Same author

Time to Identify Glaucoma Progression Given Typical Visual Field Testing Frequencies in a US Nationwide Insured Population.

Ophthalmology. Glaucoma·2025

Related Experiment Video

Updated: Jul 30, 2025

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
11:12

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

17.5K

Hazard Detection During Simulated Driving in Glaucoma Patients.

Fábio B Daga1,2, Erwin R Boer3, Alberto Diniz-Filho4

  • 1Duke Eye Center and Department of Ophthalmology, Duke University, Durham, NC.

Journal of Glaucoma
|May 12, 2023
PubMed
Summary

Glaucoma patients exhibit slower reaction times (RTs) to driving hazards compared to controls. Worse visual field loss in glaucoma correlates with these slower RTs, impacting driving safety.

More Related Videos

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.4K
Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition
07:45

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Published on: July 21, 2020

4.5K

Related Experiment Videos

Last Updated: Jul 30, 2025

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
11:12

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

17.5K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.4K
Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition
07:45

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Published on: July 21, 2020

4.5K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Human Factors Engineering

Background:

  • Glaucoma is a progressive optic neuropathy leading to characteristic visual field loss.
  • Impaired visual function in glaucoma can potentially affect driving performance and safety.
  • Driving simulation offers a controlled environment to assess driving capabilities in clinical populations.

Purpose of the Study:

  • To evaluate the impact of hazardous traffic conditions on driving performance in glaucoma patients.
  • To compare reaction times (RTs) between glaucoma patients and control subjects in simulated driving scenarios.
  • To investigate the relationship between the severity of visual field loss and RTs in glaucoma patients.

Main Methods:

  • A cross-sectional study involving 52 glaucoma patients and 15 control subjects.
  • Utilized a high-fidelity driving simulator presenting various hazardous scenarios (e.g., unexpected pedestrians, sudden lane changes).
  • Measured RTs for "Gas Off" and "Brake On" actions in response to hazards, comparing between groups and correlating with visual field parameters.

Main Results:

  • Glaucoma patients demonstrated significantly slower "Brake On" RTs (3.39±3.88s) compared to controls (2.39±1.99s; P=0.005).
  • Slower RTs in glaucoma patients were significantly associated with greater visual field loss (1.12-1.14s slower per 10dB worse sensitivity; P<0.009).
  • Glaucoma patients showed longer braking times for low-saliency hazards compared to high-saliency hazards (P=0.027).

Conclusions:

  • Glaucoma patients exhibit impaired reaction times to driving hazards compared to healthy individuals.
  • The degree of visual field loss is a significant predictor of slower reaction times in glaucoma patients.
  • Driving simulators presenting hazardous scenarios can aid in assessing driving fitness and risk for glaucoma patients.